Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice

Epilepsy Research

Volumn 108, Issue 7, 2014, Pages 1137-1144

  Mantis, John G ^a   Meidenbauer, Joshua J ^a   Zimick, Nicholas C ^a   Centeno, Nicole A ^a   Seyfried, Thomas N ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

Calorie restriction; Epilepsy; Ketones; Seizure susceptibility

Indexed keywords

3 HYDROXYBUTYRIC ACID; DRINKING WATER; GLUCOSE; GLUCOSE BLOOD LEVEL; SWEETENING AGENT;

3 HYDROXYBUTYRIC ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE MODEL; ENERGY EXPENDITURE; FEMALE; FOOD INTAKE; GENERALIZED EPILEPSY; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; KETOGENESIS; KETOGENIC DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD; WEIGHT REDUCTION; ANALYSIS OF VARIANCE; ANIMAL; BLOOD; DIET THERAPY; DOSE RESPONSE; EPILEPSY; GENETICS; INBRED MOUSE STRAIN; MALE; PROCEDURES; TIME;

3-HYDROXYBUTYRIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CALORIC RESTRICTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; GLUCOSE; KETOGENIC DIET; MALE; MICE; MICE, INBRED STRAINS; SWEETENING AGENTS; TIME FACTORS;

EID: 84904752908     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2014.05.010     Document Type: Article

References (87)

1. Ackermann R.F., Lear J.L. Glycolysis-induced discordance between glucose metabolic rates measured with radiolabeled fluorodeoxyglucose and glucose. J. Cereb. Blood Flow Metab. 1989, 9:774-785.
2. Bailey E.E., Pfeifer H.H., Thiele E.A. The use of diet in the treatment of epilepsy. Epilepsy Behav. 2005, 6:4-8.
3. Baranano K.W., Hartman A.L. The ketogenic diet: uses in epilepsy and other neurologic illnesses. Curr. Treat. Options Neurol. 2008, 10:410-419.
4. Bough K.J., Eagles D.A. A ketogenic diet increases the resistance to pentylenetetrazole-induced seizures in the rat. Epilepsia 1999, 40:138-143.
5. Bough K.J., Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007, 48:43-58.
6. Brigande J.V., Wieraszko A., Albert M.D., Balkema G.W., Seyfried T.N. Biochemical correlates of epilepsy in the El mouse: analysis of glial fibrillary acidic protein and gangliosides. J. Neurochem. 1992, 58:752-760.
7. Clarke D.D., Sokoloff L. Circulation and energy metabolism of the brain. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 1999, 637-669. Lippincott-Raven, New York. 6th ed. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
8. Coppola G., Verrotti A., Ammendola E., Operto F.F., Corte R.D., Signoriello G., Pascotto A. Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur. J. Paediatr. Neurol. 2010, 14:229-234.
9. Cornford E.M., Nguyen E.V., Landaw E.M. Acute upregulation of blood-brain barrier glucose transporter activity in seizures. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1346-H1354.
10. Cramer J.A., Mintzer S., Wheless J., Mattson R.H. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev. Neurother. 2010, 10:885-891.
11. Drage M.G., Holmes G.L., Seyfried T.N. Hippocampal neurons and glia in epileptic EL mice. J. Neurocytol. 2002, 31:681-692.
12. Eagles D.A., Boyd S.J., Kotak A., Allan F. Calorie restriction of a high-carbohydrate diet elevates the threshold of PTZ-induced seizures to values equal to those seen with a ketogenic diet. Epilepsy Res. 2003, 54:41-52.
13. Engel J.J., Pedley T.A. Introduction: what is epilepsy?. Epilepsy: A Comprehensive Textbook 1997, 1-10. Lipponcott-Raven, New York. J.J. Englel, T.A. Pedley (Eds.).
14. Flavin H.J., Seyfried T.N. Enhanced aspartate release related to epilepsy in (EL) mice. J. Neurochem. 1994, 63:592-595.
15. Fontana L. Calorie restriction and cardiometabolic health. Eur. J. Cardiovasc. Prev. Rehabil. 2008, 15:3-9.
16. Frankel W.N., Johnson E.W., Lutz C.M. Congenic strains reveal effects of the epilepsy quantitative locus, El2, separate from other El loci. Mamm. Genome 1995, 6:839-843.
17. Frankel W.N., Valenzuela A., Lutz C.M., Johnson E.W., Dietrich W.F., Coffin J.M. New seizure frequency QTL and the complex genetics of epilepsy in EL mice. Mamm. Genome 1995, 6:830-838.
18. Freeman J.M. The ketogenic diet and epilepsy. Nestle Nutr. Workshop Ser. Clin. Perform. Programme, vol. 5 2001, 307-318. discussion 318-321.
19. Freeman J.M., Freeman J.B., Kelly M.T. The Ketogenic Diet: A Treatment for Epilepsy 2000, Demos, New York. 3rd ed.
20. Freeman J.M., Kelly M.T., Freeman J.B. The Epilepsy Diet Treatment: An Introduction to the Ketogenic Diet 1996, Demos Vermande, New York. 2nd ed.
21. Freeman J.M., Kossoff E.H., Hartman A.L. The ketogenic diet: one decade later. Pediatrics 2007, 119:535-543.
22. Fueta Y., Kawano H., Ono T., Mita T., Fukata K., Ohno K. Regional differences in hippocampal excitability manifested by paired-pulse stimulation of genetically epileptic El mice. Brain Res. 1998, 779:324-328.
23. Gasior M., Rogawski M.A., Hartman A.L. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol. 2006, 17:431-439.
24. Greene A.E., Todorova M.M., Seyfried T.N. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J. Neurochem. 2003, 86:529-537.
25. Greene A.E., Todorova M.T., McGowan R., Seyfried T.N. Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 2001, 42:1371-1378.
26. Halagappa V.K., Guo Z., Pearson M., Matsuoka Y., Cutler R.G., Laferla F.M., Mattson M.P. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2007, 26:212-220.
27. Hartman A.L., Rho J.M. Beyond epilepsy: ketogenic diet use in other disease states. Dietary Treatment of Epilepsy: Practical Implementation of Ketogenic Therapy 2012, John Wiley & Sons, Ltd, Chichester, UK. E.G. Neal (Ed.).
28. Hartman A.L., Rubenstein J.E., Kossoff E.H. Intermittent fasting: a new historical strategy for controlling seizures?. Epilepsy Res. 2013, 104:275-279.
29. Helmholz H.F., Keith H.M. Eight years' experience with the ketogenic diet in the treatment of epilepsy. JAMA 1930, 95:707-709.
30. Hemingway C., Freeman J.M., Pillas D.J., Pyzik P.L. The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 2001, 108:898-905.
31. Huttenlocher P.R. Ketonemia and seizures: metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy. Pediatr. Res. 1976, 10:536-540.
32. Ikemoto A., Bole D.G., Ueda T. Glycolysis and glutamate accumulation into synaptic vesicles. Role of glyceraldehyde phosphate dehydrogenase and 3-phosphoglycerate kinase. J. Biol. Chem. 2003, 278:5929-5940.
33. Ishida N., Kasamo K., Nakamoto Y., Suzuki J. Epileptic seizure of El mouse initiates at the parietal cortex: depth EEG observation in freely moving condition using buffer amplifier. Brain Res. 1993, 608:52-57.
34. Johnston A., Smith P. Epilepsy: a general overview. Epilepsy and Intellectual Disabilities 2008, 7-29. Springer-Verlag, New York, LLC. V.P. Prasher, M.P. Kerr (Eds.).
35. Kang H.C., Chung da E., Kim D.W., Kim H.D. Early- and late-onset complications of the ketogenic diet for intractable epilepsy. Epilepsia 2004, 45:1116-1123.
36. Knowlton R.C., Abou-Khalil B., Sawrie S.M., Martin R.C., Faught R.E., Kuzniecky R.I. In vivo hippocampal metabolic dysfunction in human temporal lobe epilepsy. Arch. Neurol. 2002, 59:1882-1886.
37. Kossoff E.H., Rho J.M. Ketogenic diets: evidence for short- and long-term efficacy. Neurotherapeutics 2009, 6:406-414.
38. Kovacs Z., Kekesi K.A., Juhasz G., Dobolyi A. The antiepileptic potential of nucleosides. Curr. Med. Chem. 2014, 21:788-821.
39. Lambert J.D., Fueta Y., Roepstorff A., Andreasen M. Analysis of the kinetics of synaptic inhibition points to a reduction in GABA release in area CA1 of the genetically epileptic mouse, El. Epilepsy Res. 1996, 26:15-23.
40. Levy R.G., Cooper P.N., Giri P. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2012, 3:CD001903.
41. Libert S., Guarente L. Metabolic and neuropsychiatric effects of calorie restriction and sirtuins. Annu. Rev. Physiol. 2013, 75:669-684.
42. Likhodii S.S., Serbanescu I., Cortez M.A., Murphy P., Snead O.C., Burnham W.M. Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet. Ann. Neurol. 2003, 54:219-226.
43. Livingston S. Dietary treatment of epilepsy. Comprehensive Management of Epilepsy in Infancy, Childhood and Adolescence 1972, 378-405. Charles C. Thomas, Springfield, IL. S. Livingston (Ed.).
44. Lutas A., Yellen G. The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci. 2013, 36:32-40.
45. Mantis J.G., Centeno N.A., Todorova M.T., McGowan R., Seyfried T.N. Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab. 2004, 1:11.
46. Mantis J.G., Fritz C.L., Marsh J., Heinrichs S.C., Seyfried T.N. Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets. Epilepsy Behav. 2009, 15:133-141.
47. Marini C., Scheffer I.E., Crossland K.M., Grinton B.E., Phillips F.L., McMahon J.M., Turner S.J., Dean J.T., Kivity S., Mazarib A., Neufeld M.Y., Korczyn A.D., Harkin L.A., Dibbens L.M., Wallace R.H., Mulley J.C., Berkovic S.F. Genetic architecture of idiopathic generalized epilepsy: clinical genetic analysis of 55 multiplex families. Epilepsia 2004, 45:467-478.
48. Marsh E.B., Freeman J.M., Kossoff E.H., Vining E.P., Rubenstein J.E., Pyzik P.L., Hemingway C. The outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year. Epilepsia 2006, 47:425-430.
49. Marsh J., Mukherjee P., Seyfried T.N. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma. Clin. Cancer Res. 2008, 14:7751-7762.
50. Masino S.A., Kawamura M., Ruskin D.N., Geiger J.D., Boison D. Purines and neuronal excitability: links to the ketogenic diet. Epilepsy Res. 2012, 100:229-238.
51. Meidenbauer J.J., Mantis J.G., Seyfried T.N. The EL mouse: a natural model of autism and epilepsy. Epilepsia 2011, 52:347-357.
52. Meldrum B., Chapman A. Epileptic seizures and epilepsy. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 1999, 755-768. Lippincott-Raven, New York. 6th ed. G.J. Siegel, B.W. Agranoff, R.W. Albers, S.K. Fisher, M.D. Uhler (Eds.).
53. Murashima Y.L., Suzuki J., Yoshii M. Developmental program of epileptogenesis in the brain of EL mice. Epilepsia 2005, 46(Suppl. 5):10-16.
54. Nakano H., Saito K., Suzuki K. Chronic implantation technique for monopolar EEG monitoring of epileptic seizures in mice. Brain Res. Bull. 1994, 35:261-268.
55. Naruse H., Kurokawa M. The beginnings of studies on EL mice. Neurosciences 1992, 18(Suppl. 2):1-3.
56. Neal E.G., Chaffe H., Schwartz R.H., Lawson M.S., Edwards N., Fitzsimmons G., Whitney A., Cross J.H. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008, 7:500-506.
57. Nehlig A., Pereira de Vasconcelos A. Glucose and ketone body utilization by the brain of neonatal rats. Prog. Neurobiol. 1993, 40:163-221.
58. Owen O.E., Caprio S., Reichard G.A., Mozzoli M.A., Boden G., Owen R.S. Ketosis of starvation: a revisit and new perspectives. Clin. Endrocrinol. Metab. 1983, 12:359-379.
59. Owen O.E., Morgan A.P., Kemp H.G., Sullivan J.M., Herrera M.G., Cahill G.F. Brain metabolism during fasting. J. Clin. Invest. 1967, 46:1589-1595.
60. Poderycki M.J., Simoes J.M., Todorova M., Neumann P.E., Seyfried T.N. Environmental influences on epilepsy gene mapping in EL mice. J. Neurogenet. 1998, 12:67-86.
61. Raffo E., Francois J., Ferrandon A., Koning E., Nehlig A. Calorie-restricted ketogenic diet increases thresholds to all patterns of pentylenetetrazol-induced seizures: critical importance of electroclinical assessment. Epilepsia 2008, 49:320-328.
62. Rho J.M., Anderson G.D., Donevan S.D., White H.S. Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia 2002, 43:358-361.
63. Sampath A., Kossoff E.H., Furth S.L., Pyzik P.L., Vining E.P. Kidney stones and the ketogenic diet: risk factors and prevention. J. Child Neurol. 2007, 22:375-378.
64. Sarkisian M.R. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav. 2001, 2:201-216.
65. Sato H. The development of EEG background activities in El mouse. Folia Psychiatr. Neurol. Jpn. 1985, 39:581-587.
66. Schwechter E.M., Veliskova J., Velisek L. Correlation between extracellular glucose and seizure susceptibility in adult rats. Ann. Neurol. 2003, 53:91-101.
67. Seyfried T.N., Mantis J.G., Todorova M.T., Greene A.E. Dietary management of epilepsy: role of glucose and ketone bodies. Encyclopedia of Basic Epilepsy Research 2009, Academic Press, Oxford. P.A. Schwartzkroin (Ed.).
68. Seyfried T.N., Poderycki M.J., Todorova M.T. Genetics of the EL mouse: a multifactorial epilepsy model. Genetics of Focal Epilepsies 1999, 229-238. J. Libby, London. P. Genton, S.F. Berkovic, E. Hirsch, C. Marescaux (Eds.).
69. Sohal R.S., Ferguson M., Sohal B.H., Forster M.J. Life span extension in mice by food restriction depends on an energy imbalance. J. Nutr. 2009, 139:533-539.
70. Stafstrom C.E., Rho J.M. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front. Pharm. 2012, 3:59.
71. Suzuki J. Paroxysmal discharges in the electroencephalogram of the El mouse. Experientia 1976, 32:336-338.
72. Suzuki J. Investigations of epilepsy with a mutant animal (EL mouse) model. Epilepsia 2004, 45(Suppl. 8):2-5.
73. Suzuki J., Nakamoto Y. Seizure patterns and electroencephalograms of El mouse. Electroencephalogr. Clin. Neurophysiol. 1977, 43:299-311.
74. Suzuki J., Ozawa N., Murashima Y.L., Shinba T., Yoshii M. Neuronal activity in the parietal cortex of EL and DDY mice. Brain Res. 2012, 1460:63-72.
75. Tan N.C., Mulley J.C., Berkovic S.F. Genetic association studies in epilepsy: the truth is out there. Epilepsia 2004, 45:1429-1442.
76. Todorova M.T., Burwell T.J., Seyfried T.N. Environmental risk factors for multifactorial epilepsy in EL mice. Epilepsia 1999, 40:1697-1707.
77. Todorova M.T., Dangler C.A., Drage M.G., Sheppard B.J., Fox J.G., Seyfried T.N. Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia 2003, 44:25-31.
78. Todorova M.T., Mantis J.G., Le M., Kim C.Y., Seyfried T.N. Genetic and environmental interactions determine seizure susceptibility in epileptic EL mice. Genes Brain Behav. 2006, 5:518-527.
79. Todorova M.T., Tandon P., Madore R.A., Stafstrom C.E., Seyfried T.N. The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 2000, 41:933-940.
80. Uchibori M., Saito K., Yokoyama S., Sakamoto Y., Suzuki H., Tsuji T., Suzuki K. Foci identification of spike discharges in the EEGs of sleeping El mice based on the electric field model and wavelet decomposition of multi monopolar derivations. J. Neurosci. Methods 2002, 117:51-63.
81. Veech R.L., Chance B., Kashiwaya Y., Lardy H.A., Cahill G.F. Ketone bodies, potential therapeutic uses. IUBMB Life 2001, 51:241-247.
82. Wheless J.W. Adverse effects of antiepileptic drugs. Epilepsy in Children and Adolescents 2013, John Wiley & Sons, Ltd, Chichester, UK. J.W. Wheless (Ed.).
83. Wilder R. The effects of ketonemia on the course of epilepsy. Mayo Clin. Proc. 1921, 2:307-308.
84. Williamson D.H., Mellanby J., Krebs H.A. Enzymatic determination of d(-)-b-hydroxybutyric acid and acetoacetic acid in blood. J. Biochem. 1962, 82:90-96.
85. Yamashita M., Matsuki A., Oyama T. General anaesthesia for a patient with progressive muscular dystrophy. Der Anaesthesist 1976, 25:76-79.
86. Zhang Y., Kuang Y., Xu K., Harris D., Lee Z., LaManna J., Puchowicz M.A. Ketosis proportionately spares glucose utilization in brain. J. Cereb. Blood Flow Metab. 2013, 33:1307-1311.
87. Zhou W., Mukherjee P., Kiebish M.A., Markis W.T., Mantis J.G., Seyfried T.N. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr. Metab. 2007, 4:5.